Phase 2 Open Label Single Arm Repeat Dose Study to Assess the Effect of SNF472 on Wound Healing in Uraemic Calciphylaxis Patients
Phase of Trial: Phase II
Latest Information Update: 06 Mar 2018
At a glance
- Drugs Sodium fytate (Primary)
- Indications Calciphylaxis
- Focus Therapeutic Use
- Sponsors Laboratoris Sanifit
- 06 Mar 2018 Primary endpoint (Wound Healing:Assessment of lesion score using Bates-Jensen wound assessment tool) has been met, according to a Sanifit media release.
- 06 Mar 2018 According to a Sanifit media release, full trial results will be presented at a scientific meeting in mid-2018.
- 06 Mar 2018 According to a Sanifit media release, results for this trial were announced by the company.